Justice Markandey Katju's prescription for a regulated media regime is a misplaced step that can actually de-democratise the fourth estate. IT is open season on the political class and the news media. But then, again, it's more like a chase of one's own tail. A self-righteous, delusional, Anna-Baba NGO-ised fringe sets out to stigmatise politics and Members of Parliament; the news media salivate at the prospect and rush to provide...

AHMEDABAD: What was the need for amicus curiae Raju Ramachandran to put down these words in his final report before the Supreme Court which became public this week? "The cost for boarding and lodging for both the amicus curiae at BSF mess, Gandhinagar as well as the cost for local transportation by private taxi was arranged by the SIT...the cost of travel from Delhi to Ahmedabad and back (for both...

-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...

But non-farm income keeps economy afloat   New Delhi, April 25: The rural growth story is slowly losing sheen because of inflation and rising input costs. In fact, rural price level is higher than urban price level. The March Consumer Price Index number for rural India stood at 116.3, while that for urban India stood at 114.6. Mr Ajay Sriram, Chairman and Senior Managing Director, DCM Sriram Consolidated Ltd, says the rural growth...

Industry reacts with caution to the grant of a compulsory licence to Natco, but cancer patients welcome it and hope for many more. THE first compulsory licence (CL) issued by the Indian patent office, to the local drug manufacturer Natco Pharma Ltd to sell the generic version of Bayer AG's anti-cancer drug Nexavar, has led to varied reactions. The landmark decision has also raised concerns about the outcome of cases...